Literature DB >> 26724907

Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model.

Alvaro Plaza Reyes1, Sandra Petrus-Reurer2, Liselotte Antonsson1, Sonya Stenfelt1, Hammurabi Bartuma3, Sarita Panula1, Theresa Mader1, Iyadh Douagi4, Helder André3, Outi Hovatta5, Fredrik Lanner6, Anders Kvanta3.   

Abstract

Human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells could replace lost tissue in geographic atrophy (GA) but efficacy has yet to be demonstrated in a large-eyed model. Also, production of hESC-RPE has not yet been achieved in a xeno-free and defined manner, which is critical for clinical compliance and reduced immunogenicity. Here we describe an effective differentiation methodology using human laminin-521 matrix with xeno-free and defined medium. Differentiated cells exhibited characteristics of native RPE including morphology, pigmentation, marker expression, monolayer integrity, and polarization together with phagocytic activity. Furthermore, we established a large-eyed GA model that allowed in vivo imaging of hESC-RPE and host retina. Cells transplanted in suspension showed long-term integration and formed polarized monolayers exhibiting phagocytic and photoreceptor rescue capacity. We have developed a xeno-free and defined hESC-RPE differentiation method and present evidence of functional integration of clinically compliant hESC-RPE in a large-eyed disease model.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cellular therapy; differentiation; human embryonic stem cells; laminin; optical coherence tomography; rabbit; retinal pigment epithelium; transplantation; xeno-free

Mesh:

Substances:

Year:  2015        PMID: 26724907      PMCID: PMC4720022          DOI: 10.1016/j.stemcr.2015.11.008

Source DB:  PubMed          Journal:  Stem Cell Reports        ISSN: 2213-6711            Impact factor:   7.765


Introduction

Age-related macular degeneration (AMD), the most common cause of severe vision loss in the Western world, occurs in wet (neovascular) and dry (degenerative) forms. In early dry AMD, the retinal pigment epithelium (RPE) becomes dysfunctional, whereas end-stage disease, geographic atrophy (GA), is characterized by degeneration of RPE and photoreceptors (Bhutto and Lutty, 2012). The RPE is a monolayer of polarized cells that constitutes the outer blood-retina barrier and performs central tasks in the eye, e.g., light adsorption, secretion of growth factors, and phagocytosis of photoreceptor outer segments (POS) (Sparrow et al., 2010). The apical surface harbors microvilli that interact with the light-sensitive POS, whereas the basolateral surface adheres to Bruch's membrane (BM), which in turn separates the RPE from the underlying choroid. Subretinal transplantation of RPE cells derived from human embryonic stem cells (hESC) could potentially be used as replacement therapy in GA (Schwartz et al., 2012, Schwartz et al., 2015). However, a critical question is whether donor cells integrate into the host RPE and support the overlying photoreceptors. Experimental transplantations of hESC-RPE have only been conducted in small-eyed rodent models (Carido et al., 2014, Idelson et al., 2009, Lund et al., 2006, Vugler et al., 2008). Functional effects in these models are however non-specific and surgical techniques, instrumentation, and imaging methods differ from those applied in humans, limiting their use as preclinical models (e.g., Pinilla et al., 2009). We have recently described a damage model in the large-eyed rabbit that exhibits typical GA changes including photoreceptor loss and RPE alterations (Bartuma et al., 2015). Several hESC-RPE derivation protocols have been described with the common limitation of relying on culture steps that involve xeno- or human-feeder cells or use medium components that are either undefined or not xeno-free (Klimanskaya et al., 2004, Lane et al., 2014, Osakada et al., 2009, Pennington et al., 2015, Vaajasaari et al., 2011). Recently, we described a defined and xeno-free clonal culture of hESC using recombinant human laminin (rhLN) and E-cadherin (Rodin et al., 2014a, Rodin et al., 2014b). Encouraged by this work, we set out to evaluate whether rhLN-matrix could support efficient hESC-RPE differentiation. BM, the RPE basement membrane, contains four LNs, LN-111, LN-332, LN-511, and LN-521, that adhere to the RPE via specific integrins (Aisenbrey et al., 2006). In the present study, we show that rhLNs are more effective in supporting xeno-free and defined differentiation compared with exogenous matrix such as gelatin, used in ongoing clinical studies (Schwartz et al., 2012). Moreover, we demonstrate that suspension transplantations of rhLN-521-hESC-RPE integrate as polarized subretinal monolayers that rescue overlying photoreceptors from induced damage. We conclude that rhLN-521 effectively supports differentiation of clinically compliant hESC-RPE, and presents evidence of efficient long-term functional integration of hESC-RPE in a large-eyed disease model.

Results

Robust Induction of Primary Pigmented Cells Using Suspension Differentiation in Defined Medium

We have recently developed a xeno-free hESC derivation and culture methodology, using rhLN-521-based matrix and a xeno-free and defined NutriStem hESC XF medium containing basic fibroblast growth factor (bFGF) (Rodin et al., 2014a, Rodin et al., 2014b). As FGF removal is critical for RPE differentiation (Pittack et al., 1997), we decided to evaluate whether our hESC culture methodology could efficiently support hESC-RPE differentiation following bFGF removal. hESCs were cultured on rhLN-521 and manually scraped to produce a suspension culture of embryoid bodies (EBs) in NutriStem hESC XF without bFGF (Figures 1A and 1B). This culture robustly supported formation of pigmented structures resembling optical vesicles (OVs) at as early as 3 weeks of differentiation (Figures 1A and 1B). At this stage, we observed an average of 0.3 OVs per EB, which in the subsequent weeks increased to 0.8 per EB (Figure 1C). This efficiency of OV induction is well in line with previous reports (Idelson et al., 2009), confirming that our xeno-free culture medium efficiently supports the first stage of hESC-RPE differentiation.
Figure 1

Xeno-Free and Defined RPE Differentiation of hESC to hESC-RPE

(A) Differentiation protocol scheme. Confluent hESC cultures were scraped and cultured in low-attachment plates with NutriStem −/− (bFGF removed) to form EBs with Rock inhibitor during the first 24 hr. First pigmentation (OV-like structures) appears following week 3. At week 5, pigmented structures are cut out with a scalpel and dissociated into single cells. Cells are plated on different substrates and cultured until homogeneous pigmentation is reached (week 9). RPE cells are dissociated to a single-cell suspension for subretinal injection in the rabbit eye.

(B) hESC-EB with pigmented OV-like structures.

(C) Quantification of pigmented OV formation per starting EB during differentiation. Bars represent means ± SD from three independent experiments.

(D) Differentiation on gelatin and LN-111, LN-332, LN-511, and LN-521 following 21 and 32 days. See also Movie S1.

(E) Images depicting the migratory tracks of ten random cells during the first 7 days of culture on the different conditions.

(F) Bar graph showing the average length migrated by cells growing on the different substrates. Three individual wells with ten cells analyzed in each were quantified over a period of 7 days using time-lapse imaging. Bars represent means ± SD.

(G) Transcriptional analysis of hESC-RPE differentiated on the different substrates. Values are normalized to RPLPO and GAPDH and displayed as relative to undifferentiated hESCs. Bars represent means ± SEM from three independent experiments.

(H) Flow cytometry analysis of MITF expression on hESC-RPE cells grown on the different substrates for 29 days.

(I and J) Polarized secretion of VEGF and PEDF in hESC-RPE. Bars represent means ± SEM from three independent experiments.

(K) Phagocytosis of fluorescein isothiocyanates (FITC)-labeled POS by hESC-RPE on the different substrates. hESC-RPE cells incubated with FITC-labeled POS at 4°C were used as negative controls. Bars represent means ± SD from three independent experiments.

(L) TER measurements of hESC-RPE cells grown on the different substrates. The TER value for undifferentiated hESCs (fully confluent plate) is shown for comparison (dashed line). Bars represent means ± SEM from three independent experiments.

Scale bars: B, D, E, 500 μm.

See also Figure S1.

rhLN-521 Efficiently Supports Homogeneous Expansion of Pigmented and Functional hESC-RPE

Endogenous BM contains four LNs: LN-111, LN-332, LN-511, and LN-521. Consequently, we decided to compare subsequent expansion and maturation of primary pigmented cells on gelatin or rhLNs found in the endogenous BM. The pigmented OVs were mechanically cut out using a scalpel and dissociated into single cells. Cells were seeded through a cell strainer onto gelatin or LN-coated dishes. Three days following plating, it was clearly observable that LN-521 had the best performance, with 69% plating efficiency compared with 8% in gelatin-coated cultures (Table S1). Pigmentation was initially lost in all cultures, but was progressively reestablished from day 21 (Figure 1D), as previously described. Interestingly, time-lapse microscopy showed that cells on rhLN-511 and rhLN-521 were highly migratory forming uniform monolayers throughout the wells (Figures 1D–1F and Movie S1), while progressively maturing into pigmented hexagonal cells. This correlates well with a previous study showing that the same subtype of integrin receptors recognizes LN-511 and LN-521 (Aisenbrey et al., 2006). Cells on gelatin were migratory, but tended to stay in tight colonies and failed to fully cover the plate even after 77 days (Figures 1D–1F and S1A). Transcriptional analysis showed similar profiles in hESC-RPE differentiated on each of the five substrates with reduction of pluripotency-associated transcripts OCT3/4 and NANOG, together with robust expression of neuroectoderm transcripts sex-determining region Y-box 9 protein (SOX9) and paired box 6 (PAX6). Low expression levels of paired box 3 (PAX3) and endothelin receptor B (EDNRB) transcripts eliminated the possibility of contaminating melanocytes in any of the substrates (Figure S1B). RPE differentiation was evident with expression of bestrophin 1 (BEST1), RPE-specific protein 65 kDa (RPE65), and premelanosome protein (PMEL) (Figure 1G). However, more sensitive single-cell analysis of mature RPE purity through flow cytometry for microphthalmia-associated transcription factor (MITF) and BEST1 showed more homogeneous expression on all LNs compared with gelatin (Figures 1H and S1C). Functionally, all cultures showed polarized secretion of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF), as well as active phagocytosis of POS (Figures 1I–K and S1D–S1G). hESC-RPE only secreted PEDF from week 5 and not earlier (data not shown). We found that hESC-RPE growing on LN-332 and gelatin displayed lower levels of PEDF secretion compared with those growing in all the other tested conditions. Also, interestingly, transepithelial electrical resistance (TER) measurements proved the functional tight junction integrity of our hESC-RPE monolayer on LN-111, LN-511, and LN-521 in a time-dependent manner, but not on LN-332 and gelatin (Figure 1L). This observation is in line with the fact that RPE cells did not manage to form a continuous monolayer when growing on these two substrates (Figures 1D and S1A). hESC-RPE seeded on LN-521 reached values of 180 Ω cm2 after 31 days, indicative of a functionally mature monolayer. Extended analysis confirmed that rhLN-521-hESC-RPE cultures acquired a pigmented and hexagonal morphology (Figures 2A and 2B), and they were also shown to be uniformly positive for cellular retinaldehyde-binding protein (CRALBP) and BEST1 with clear apical polarization of zonula occludens protein 1 (ZO-1) and Na/K-ATPase (Figures 2C–2H).
Figure 2

Morphology and Marker Expression of rhLN-521-hESC-RPE

(A) Bright-field image of hESC-RPE cells grown on rhLN-521 acquiring hexagonal shape before pigmentation.

(B) Mature and highly pigmented hESC-RPE cells displaying hexagonal morphology.

(C–F) Expression of key RPE markers: cellular retinaldehyde-binding protein (CRALBP), zonula occludens protein-1 (ZO-1), Na/K-ATPase, and Bestrophin1 (Best1) by immunostaining.

(G and H) Z-stack confocal projections showing polarized expression of ZO-1 and Na/K-ATPase markers on the apical side of the hESC-RPE.

Scale bars: A, B, 100 μm; C–H, 20 μm.

hESC-RPE Transplantation into Albino Rabbits

For transplantation, we chose the albino rabbit with an eye size approximately 70% of that the human eye. All major retinal and subretinal layers were clearly detectable using cross-sectional spectral domain optical coherence tomography (SD-OCT) (Figures S2A and S2B). We next transplanted suspensions of rhLN-521-hESC-RPE into the subretinal space. Pigmentation was not evident by ophthalmoscopy but a thickened and irregular RPE/BM layer was detected by SD-OCT 1 week after transplantation (Figure S2C). Histologic analysis demonstrated a monolayer of lightly pigmented cells that integrated into the host RPE overlaid by well-preserved photoreceptors (Figure 3A). Positive immunostaining for human nuclear mitotic apparatus protein (NuMA) confirmed the human origin of the cells (Figure 3B). Eight weeks after transplantation, monolayers of cells had become heavily pigmented and acquired a polarized phenotype as demonstrated by basolateral expression of BEST1 in the injected area (Figures 3C–3E and S2E). Importantly, all NuMA-positive cells were also pigmented and BEST1-positive. Pigmented rhLN-521-hESC-RPE monolayers with preservation of the neurosensory retina were further observed for up to 34 weeks (Figures 3F, S2C, and S2D). Donor cells were positive for the specific RPE marker RPE65 and cytoplasmic rhodopsin suggestive of maintained phagocytic activity (Figures 3G and 3H).
Figure 3

In Vivo Integration of rhLN-521-hESC-RPE

(A) H&E-stained section 1 week after transplantation demonstrates the presence of lightly pigmented cells as a continuous monolayer (arrows) between the POS and the underlying choriocapillaris.

(B) Subretinal human (NuMA-positive) cells detected in the injected region. Panels show NuMA (B1), DAPI (B2) and NuMA with DAPI (B3).

(C) A heavily pigmented subretinal monolayer of transplanted cells is detected in the injected region 8 weeks after transplantation.

(D and E) 8 weeks after transplantation, the integrated NuMA-positive rhLN-521-hESC-RPE cells are polarized with basolateral BEST1 expression. BF, bright field. Panels show BEST1 with BF (D1) and BEST1 only (D2).

(F–H) 34 weeks after transplantation, a heavily pigmented monolayer is present in the injected region displaying RPE65-positive cells and engulfment of rhodopsin-positive particles. Dashed lines represent individual nuclei.

(I) The non-pigmented native RPE layer (arrows) of an untreated area is shown for comparison.

Scale bars: A–C, 10 μm; D, 100 μm; E–I, 10 μm.

In Vivo Photoreceptor Rescue by hESC-RPE

In the albino rabbit, subretinal injection of PBS alone creates a GA-like phenotype including photoreceptor loss (Bartuma et al., 2015). We therefore tested whether transplanted rhLN-521-hESC-RPE possessed photoreceptor rescue capacity. The outer nuclear layer (ONL), normally consisting of five to six layers, was reduced to a single layer in PBS-injected eyes (Figure 4A), whereas eyes transplanted with rhLN-521-hESC-RPE had preserved ONL and POS (Figure 4B). Integration of transplanted cells was further necessary for ONL rescue as outer retinal thickness (ORT) measurements in eyes with minimal or no integration were similar to those with PBS treatment alone (Figures 4C–4E). Importantly, undifferentiated hESCs and fibroblasts that formed transient cell aggregates were not protective of photoreceptor loss (Figures S3A and S3B). Thus, the photoreceptor rescue model showed evidence of both specificity (i.e., non-RPE cells were ineffective) and sensitivity (i.e., only integrated RPE cells were effective) for functional RPE.
Figure 4

Photoreceptor Rescue by Transplanted rhLN-521-hESC-RPE

(A) PBS-induced photoreceptor degeneration is shown as a hyperreflective circle and outer retinal thinning by infrared-confocal scanning laser ophthalmoscopy (A1) and SD-OCT (A2) respectively. Green arrow, SD-OCT scan plane. A H&E stained section of the bleb transition zone (arrowhead, A3) is shown with the normal (A4) and degenerated (arrowheads, A5) photoreceptor layer magnified. ORT is indicated (arrow).

(B) Two months after transplantation, large pigmented areas are shown (B1) with integrated rhLN-521-hESC-RPE shown as a hyperreflective band (between arrowheads, B2). The overlying neurosensory retina is well preserved as demonstrated by SD-OCT (B2) and histology (B3, B4). ORT is indicated (arrow).

(C–E) ORT is significantly greater in eyes with integrated (defined as a pigmented area >2.5 mm2) than with non-integrated (defined as a pigmented area <2.5 mm2) rhLN-521-hESC-RPE. The ORT for PBS injection alone is adapted from Bartuma et al. (2015) and shown for comparison (dashed line, E). Bars represent means ± SD from 14 injected eyes. See also Supplemental Experimental Procedures.

Scale bars: A1, A2, B1, B2, 200 μm; A3, A4, A5, B3, B4, 50 μm. ∗∗p < 0.01 (2-sided Student's t test).

See also Figures S2 and S3.

Discussion

Our differentiation method based on rhLN-521 completely eliminates undefined and animal-based products throughout the process from derivation of hESCs to differentiated functional hESC-RPE. Using our approach, we can avoid microbial contamination, including new agents that have not yet been identified. In addition, we can prevent the identified risk of rejection potentially brought by non-human proteins into the cells during culture and/or differentiation (Aisenbrey et al., 2006). Key to our methodology is the combined use of xeno-free and defined culture medium with a relevant extracellular matrix. BM supporting the RPE contains collagen types I, II, and IV, fibronectin, heparin sulfate proteoglycans, and LNs: LN-111, LN-332, LN-511, and LN-521 (Campochiaro et al., 1986, Martin et al., 2005). As recombinant mouse LN-111 has been shown to support RPE differentiation (Rowland et al., 2013) and we have shown that LN-521 supports derivation and culture of hESCs (Rodin et al., 2014b), we set out to evaluate LNs in a xeno-free and defined differentiation to functional RPE. In accordance with previous observations, we found that rhLN-511 and rhLN-521 supported the highest degree of migration (Aisenbrey et al., 2006), which allowed the cells to spread out evenly in the culture plates. Interestingly, TER assessment from human adult retinal explants and immortalized RPE cell lines has been reported to reach 148 and 100 Ω cm2, respectively (Hornof et al., 2005). In our culture, cells seeded on LN111, LN511, and especially on LN521 appear to be as good as human eye explants and superior to immortalized RPE cell lines in creating highly polarized monolayers. Gelatin-coated cultures instead generated tight and irregularly shaped colonies, which failed to fully cover the plate and displayed a poor monolayer functional integrity. All substrates generated cells with similar transcriptional in vitro profiles, but single-cell analysis of MITF and BEST1 revealed significant heterogeneity in gelatin cultures compared with all LN cultures. Expanding cells in suboptimal culture conditions have the inherent risk of selecting for growth-promoting genetic abnormalities. It was therefore encouraging that seeding efficiency on rhLN-521 was 69%, compared with 8% on gelatin. From these in vitro observations, we conclude that rhLN-521 not only eliminates the need for undefined or xeno-derived matrix components but is in fact a more supportive and suitable culture matrix for hESC-RPE. Upon transplantation, integrated cells initially displayed reduced pigmentation, which was progressively reestablished, similar to what was observed during in vitro hESC-RPE derivation. Concomitantly, integration of donor cells varied both between animals and between eyes of the same animal. A putative explanation is xeno-graft rejection, as failure of integration correlated with signs of immunoreaction including subretinal cell infiltration, retinal atrophy, and donor cell loss. Optimization of our immunosuppressive protocol may thus overcome this variation. In addition, integration may depend on the state of the native RPE as transplanted cells could adhere better to a denuded BM as shown in mice with sodium iodate-induced RPE atrophy (Carido et al., 2014). Accordingly, we have shown that subretinal injection alone causes disturbed RPE morphology and partial RPE loss (Bartuma et al., 2015). In this study, we transplant hESC-RPE to a large-eyed animal. Human and rabbit eyes are of similar size, the main advantage compared with previously studied mouse and rat models (Carido et al., 2014, Lund et al., 2006). Transplantation in rodents requires high cell concentrations (i.e., typically 50,000 cells/μl or more) and a transscleral approach through the choroid (Vugler et al., 2008). The outer blood-retinal barrier is thus compromised, potentially triggering an inflammatory response. Moreover, high cell concentrations and limited surgical control may cause misdirection, multilayering, and clumping of transplanted cells. Indeed, several publications have shown that photoreceptor rescue is neither RPE specific nor correlated with an intact donor cell layer (eg. Pinilla et al., 2009). The large-eyed rabbit allowed us to perform a surgical technique with instrumentation identical to a clinical setting (el Dirini et al., 1992). The model also permitted high-resolution in vivo tracking of transplanted cells and monitoring of the overlying neurosensory retina through time. Using this methodology, we demonstrated subretinal monolayers of rhLN-521-hESC-RPE that remained for up to 8 months. Furthermore, integrated cells possessed in vivo functionality including phagocytic activity and rescue of photoreceptors from induced degeneration. Importantly, this effect showed both specificity and sensitivity as non-RPE and non-integrated RPE cells were ineffective. Suspension transplants have been frequently used in rodent models (Carido et al., 2014, Idelson et al., 2009, Lund et al., 2006, Vugler et al., 2008) and ongoing clinical studies (Schwartz et al., 2012, Schwartz et al., 2015). Concerns about this delivery method were raised with the main criticism being possible multilayering of donor cells leading to inefficient integration (Schwartz et al., 2012). As an alternative, transplantation of cells as prepolarized sheets with or without a supporting biomatrix has been suggested (Diniz et al., 2013, Stanzel et al., 2014). However, these large transplants are surgically demanding and may lead to retinal scarring and outer retinal degeneration (Kamao et al., 2014, Stanzel et al., 2014). In the present study, we noted minimal retinal scarring and a well-preserved neurosensory retina overlying the transplanted monolayer. Moreover, by using suspension transplants, we obtained monolayers up to ten times the size of RPE sheets with a typical size of 2–2.5 mm2 (Kamao et al., 2014, Stanzel et al., 2014). We demonstrate that a minimally invasive surgical procedure in a large-eyed disease model can achieve high-yield functional long-term hESC-RPE integration with photoreceptor preservation. These findings have important implications for ongoing and future clinical studies for the development of a safe and efficient cell replacement therapy for GA.

Experimental Procedures

Cell Culture and Differentiation

hES line HS980 was established and cultured under xeno-free and defined conditions on rhLN-521, and passaged as previously described (Diniz et al., 2013, Rodin et al., 2014b). For differentiation, cells were scraped and cultured in low-attachment plates, 5–7 × 104 cells/cm2 in custom-made NutriStem hESC XF medium without bFGF and transforming growth factor β. Rho-kinase inhibitor was included during the first 24 hr. Following differentiation, pigmented areas were cut out using a scalpel, dissociated, passed through a 20G needle, and plated at a density of 0.6–1.2 × 104 cells/cm2.

Subretinal Transplantation and In Vivo Imaging

Dissociated hESC-RPE cells were injected (50 μl, 50,000 cells) subretinally using a transvitreal pars plana technique. SD-OCT and confocal scanning laser ophthalmoscopy was performed to obtain horizontal cross-sectional b scans and en face fundus in vivo images, respectively.

Author Contributions

A.P.R., S.P.R., H.B. I.D., and A.K. performed the experiments. L.A., S.S., S.P., and T.M. contributed to the in vitro differentiation methodology. H.B. and H.A. contributed to the animal work. A.P.R., S.P.R., O.H., F.L., and A.K. planned the experiments, analyzed the data, and wrote the manuscript.
  27 in total

1.  Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.

Authors:  Teisha J Rowland; Alison J Blaschke; David E Buchholz; Sherry T Hikita; Lincoln V Johnson; Dennis O Clegg
Journal:  J Tissue Eng Regen Med       Date:  2012-04-18       Impact factor: 3.963

Review 2.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

3.  Embryonic stem cell trials for macular degeneration: a preliminary report.

Authors:  Steven D Schwartz; Jean-Pierre Hubschman; Gad Heilwell; Valentina Franco-Cardenas; Carolyn K Pan; Rosaleen M Ostrick; Edmund Mickunas; Roger Gay; Irina Klimanskaya; Robert Lanza
Journal:  Lancet       Date:  2012-01-24       Impact factor: 79.321

4.  Intraretinal processing following photoreceptor rescue by non-retinal cells.

Authors:  I Pinilla; N Cuenca; G Martínez-Navarrete; R D Lund; Y Sauvé
Journal:  Vision Res       Date:  2009-06-02       Impact factor: 1.886

5.  Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment.

Authors:  Sergey Rodin; Liselotte Antonsson; Colin Niaudet; Oscar E Simonson; Elina Salmela; Emil M Hansson; Anna Domogatskaya; Zhijie Xiao; Pauliina Damdimopoulou; Mona Sheikhi; José Inzunza; Ann-Sofie Nilsson; Duncan Baker; Raoul Kuiper; Yi Sun; Elisabeth Blennow; Magnus Nordenskjöld; Karl-Henrik Grinnemo; Juha Kere; Christer Betsholtz; Outi Hovatta; Karl Tryggvason
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

6.  Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer.

Authors:  Bruno Diniz; Padmaja Thomas; Biju Thomas; Ramiro Ribeiro; Yuntao Hu; Rodrigo Brant; Ashish Ahuja; Danhong Zhu; Laura Liu; Michael Koss; Mauricio Maia; Gerald Chader; David R Hinton; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-26       Impact factor: 4.799

Review 7.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

Authors:  Imran Bhutto; Gerard Lutty
Journal:  Mol Aspects Med       Date:  2012-04-21

8.  Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells.

Authors:  Hanna Vaajasaari; Tanja Ilmarinen; Kati Juuti-Uusitalo; Kristiina Rajala; Niina Onnela; Susanna Narkilahti; Riitta Suuronen; Jari Hyttinen; Hannu Uusitalo; Heli Skottman
Journal:  Mol Vis       Date:  2011-02-22       Impact factor: 2.367

9.  Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells.

Authors:  Maria Idelson; Ruslana Alper; Alexey Obolensky; Etti Ben-Shushan; Itzhak Hemo; Nurit Yachimovich-Cohen; Hanita Khaner; Yoav Smith; Ofer Wiser; Michal Gropp; Malkiel A Cohen; Sharona Even-Ram; Yael Berman-Zaken; Limor Matzrafi; Gideon Rechavi; Eyal Banin; Benjamin Reubinoff
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

10.  Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation.

Authors:  Anthony Vugler; Amanda-Jayne Carr; Jean Lawrence; Li Li Chen; Kelly Burrell; Andrew Wright; Peter Lundh; Ma'ayan Semo; Ahmad Ahmado; Carlos Gias; Lyndon da Cruz; Harry Moore; Peter Andrews; James Walsh; Peter Coffey
Journal:  Exp Neurol       Date:  2008-09-27       Impact factor: 5.330

View more
  27 in total

1.  Targeting the cAMP and Transforming Growth Factor-β Pathway Increases Proliferation to Promote Re-Epithelialization of Human Stem Cell-Derived Retinal Pigment Epithelium.

Authors:  Parul Choudhary; Alex Gutteridge; Emma Impey; R Ian Storer; Robert M Owen; Paul J Whiting; Magda Bictash; Caroline L Benn
Journal:  Stem Cells Transl Med       Date:  2016-04-25       Impact factor: 6.940

Review 2.  CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.

Authors:  Erin R Burnight; Joseph C Giacalone; Jessica A Cooke; Jessica R Thompson; Laura R Bohrer; Kathleen R Chirco; Arlene V Drack; John H Fingert; Kristan S Worthington; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2018-03-22       Impact factor: 21.198

3.  The Role of FGF9 in the Production of Neural Retina and RPE in a Pluripotent Stem Cell Model of Early Human Retinal Development.

Authors:  David M Gamm; Eric Clark; Elizabeth E Capowski; Ruchira Singh
Journal:  Am J Ophthalmol       Date:  2019-05-10       Impact factor: 5.258

4.  Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy.

Authors:  Sandra Petrus-Reurer; Hammurabi Bartuma; Monica Aronsson; Sofie Westman; Fredrik Lanner; Anders Kvanta
Journal:  J Vis Exp       Date:  2018-01-22       Impact factor: 1.355

Review 5.  Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.

Authors:  Mingyue Luo; Youxin Chen
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

6.  Stem Cell-based Treatment Strategies for Degenerative Diseases of the Retina.

Authors:  Deepthi S Rajendran Nair; Biju B Thomas
Journal:  Curr Stem Cell Res Ther       Date:  2022       Impact factor: 3.758

7.  Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method.

Authors:  Heidi Hongisto; Tanja Ilmarinen; Meri Vattulainen; Alexandra Mikhailova; Heli Skottman
Journal:  Stem Cell Res Ther       Date:  2017-12-29       Impact factor: 6.832

8.  Stem Cell Derived Retinal Pigment Epithelium: The Role of Pigmentation as Maturation Marker and Gene Expression Profile Comparison with Human Endogenous Retinal Pigment Epithelium.

Authors:  A Bennis; J G Jacobs; L A E Catsburg; J B Ten Brink; C Koster; R O Schlingemann; J van Meurs; T G M F Gorgels; P D Moerland; V M Heine; A A Bergen
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

Review 9.  Progress of stem/progenitor cell-based therapy for retinal degeneration.

Authors:  Zhimin Tang; Yi Zhang; Yuyao Wang; Dandan Zhang; Bingqiao Shen; Min Luo; Ping Gu
Journal:  J Transl Med       Date:  2017-05-10       Impact factor: 5.531

Review 10.  Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD).

Authors:  Mark Fields; Hui Cai; Jie Gong; Lucian Del Priore
Journal:  Cells       Date:  2016-12-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.